The Trump administration is in negotiations to obtain popular weight-loss drug Ozempic at a dramatically reduced price in the United States, according to President Donald Trump.
The drug, made by Danish manufacturer Novo Nordisk, will be sold at most-favored nation pricing, meaning the lowest price available in developed countries.